Latest filings (excl ownership)
RW
Registration withdrawal request
25 Apr 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
23 Apr 24
424B3
Prospectus supplement
22 Apr 24
D
$1.00 mm in equity / options / securities to be acquired, sold $1.00 mm, 1 investor
9 Apr 24
8-K
Amendments to Articles of Incorporation or Bylaws
3 Apr 24
8-K
Entry into a Material Definitive Agreement
26 Mar 24
S-1
IPO registration
27 Feb 24
10-Q
2024 Q3
Quarterly report
20 Feb 24
NT 10-Q
Notice of late quarterly filing
14 Feb 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
2 Feb 24
10-Q
2024 Q2
Quarterly report
14 Nov 23
8-K
Entry into a Material Definitive Agreement
6 Nov 23
8-K
Entry into a Material Definitive Agreement
20 Sep 23
424B5
Prospectus supplement for primary offering
19 Sep 23
8-K
Biotricity Reports Strong Growth for its First Quarter Fiscal Year 2024 and Provides Financial Results and Business Updates
17 Aug 23
10-Q
2024 Q1
Quarterly report
14 Aug 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4 Aug 23
424B3
Prospectus supplement
20 Jul 23
8-K
Other Events
20 Jul 23
8-K
Results of Operations and Financial Condition
5 Jul 23
10-K
2023 FY
Annual report
29 Jun 23
8-K
Entry into a Material Definitive Agreement
18 May 23
8-K
Departure of Directors or Certain Officers
3 Apr 23
DEFA14A
Additional proxy soliciting materials
22 Mar 23
DEF 14A
Definitive proxy
13 Mar 23
PRE 14A
Preliminary proxy
2 Mar 23
10-Q
2023 Q3
Quarterly report
14 Feb 23
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
27 Jan 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
20 Jan 23
8-K
Biotricity Reports Financial Results for Fiscal 2023 Second Quarter
18 Nov 22
10-Q
2023 Q2
Quarterly report
14 Nov 22
8-K
Biotricity Reports Financial Results for Fiscal 2023 First Quarter
16 Aug 22
10-Q
2023 Q1
Quarterly report
15 Aug 22
8-K
Departure of Directors or Certain Officers
11 Aug 22
8-K
Biotricity Reports Financial Results for Fiscal 2022 Fourth Quarter and Full Year
15 Jul 22
10-K
2022 FY
Annual report
14 Jul 22
NT 10-K
Notice of late annual filing
29 Jun 22
8-K
Departure of Directors or Certain Officers
6 May 22
424B5
Prospectus supplement for primary offering
27 Apr 22
EFFECT
Notice of effectiveness
26 Apr 22
Latest ownership filings
4
David A Rosa
15 Mar 23
4
Waqaas Al-Siddiq
14 Mar 23
4
John Ayanoglou
13 Mar 23
4
David A Rosa
9 Sep 22
3
Chester P White
1 Sep 22
3
Ronald W. McClurg
16 May 22
4
Norman M. Betts
6 Dec 21
4
David A Rosa
3 Dec 21
4
David A Rosa
13 Oct 21
4
David A Rosa
29 Sep 21
3
Stephen Salmon
17 Jul 20
SC 13D
Al-Siddiq Waqaas
29 Jun 20
4/A
Waqaas Al-Siddiq
3 Jun 20
4
Patricia J Kennedy
10 Apr 20
4
Waqaas Al-Siddiq
9 Apr 20
4
David A Rosa
9 Apr 20
4
Norman M. Betts
9 Apr 20
3
Norman M. Betts
28 Aug 19
3
David A Rosa
28 Aug 19
3
Patricia J Kennedy
19 Aug 19
3
John Ayanoglou
1 Aug 19
3
Waqaas Al-Siddiq
1 Aug 19